Framework proposes expanded quality management standards for all medical device stakeholders, suggesting improvements for better compliance.
ISO 13485:2016 is an internationally recognized standard that specifies requirements for establishing and maintaining a quality management system (QMS) in the medical device industry. It provides a structured framework to support manufacturers in consistently ensuring product quality, thereby enhancing patient safety, product effectiveness, and compliance with applicable regulatory requirements. However, its applicability to non-manufacturing stakeholders, such as integrators, operators, distributors, and service providers, remains limited. Drawing on insights from the NEMECYS Horizon Europe project, which implemented four diverse case studies spanning the full medical device lifecycle, this paper identifies key shortcomings in the standard’s current scope and structure. These include gaps in addressing postproduction activities, inter-stakeholder collaboration, and processes such as training, awareness, and decommissioning. We propose potential improvements, including clarifying target audiences, extending lifecycle coverage, and reorganizing requirements to meaningfully include non-manufacturers. By highlighting these limitations and suggesting enhancements, this work provides a framework for evolving ISO 13485:2016 into a more comprehensive standard applicable across the entire medical device ecosystem, thereby supporting consistent quality and safety for all stakeholders.
No takes yet. Share an insight, caveat, or question.
Ntanis et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: